SciELO - Scientific Electronic Library Online

 
vol.29 issue5Study about the ability of the pulmonary aerostasia, in animal model, using differents parenchymal pulmonary types of the suturesResolution of right-to-left shunt after primary pulmonary hypertension treatment with sildenafil author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Jornal de Pneumologia

Print version ISSN 0102-3586On-line version ISSN 1678-4642

Abstract

SOUZA, Eduardo José do Rosário e; GARIB, Junia Rios; GARIB, Nasim Michel  and  PADUA, Paulo Madureira de. Sildenafil for treatment of pulmonary hypertension in association with systemic lupus erythematosus and anti-phospholipid syndrome. J. Pneumologia [online]. 2003, vol.29, n.5, pp.302-304. ISSN 0102-3586.  http://dx.doi.org/10.1590/S0102-35862003000500009.

Severe pulmonary hypertension is a debilitating disease with short life expectancy that often affects young people. Pleuropulmonary complications of systemic lupus erythematosus occur in 50-70% of patients. Severe symptomatic pulmonary hypertension in systemic lupus erythematosus is rare and carries a bad prognosis because a fatal outcome can occur within months. The authors describe, for the first time, a patient with systemic lupus erythematosus with severe pulmonary hypertension and secondary antiphospholipid syndrome who responded favorably to oral sildenafil, after unsuccessful use of prednisone, intravenous cyclophosphamide, warfarin and diltiazem.

Keywords : Vasodilator agents [therapeutic use]; Lupus erythematosuos systemic; Antiphospholipid antibodies; Phosphodiesterase inhibitors.

        · abstract in Portuguese     · text in English | Portuguese     · Portuguese ( pdf epdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License